Studies have shown that tan IIA increases the expression of GSK-3β by inhibiting the β-arrestin1 and PI3K/Akt signaling pathways, further reducing the nuclear localization of β-catenin and blocking the EMT in CRC and HCC cells (Zhang et al., 2019; Song et al., 2020). This evidence concerns the gene AKT1 and colorectal carcinoma.